1,3-dipropyl-8-cyclopentylxanthine has been researched along with Carcinoma, Renal Cell in 1 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "However, the role of A1R in renal cell carcinoma (RCC) remains not well-known." | 1.46 | The Adenosine A1 Receptor Antagonist DPCPX Inhibits Tumor Progression via the ERK/JNK Pathway in Renal Cell Carcinoma. ( Chu, X; Dai, Y; Deng, F; Tang, J; Tang, Y; Tong, L; Zhou, Y, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, Y | 1 |
| Tong, L | 1 |
| Chu, X | 1 |
| Deng, F | 1 |
| Tang, J | 1 |
| Tang, Y | 1 |
| Dai, Y | 1 |
1 other study available for 1,3-dipropyl-8-cyclopentylxanthine and Carcinoma, Renal Cell
| Article | Year |
|---|---|
The Adenosine A1 Receptor Antagonist DPCPX Inhibits Tumor Progression via the ERK/JNK Pathway in Renal Cell Carcinoma.
Topics: Adenosine A1 Receptor Antagonists; Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferat | 2017 |